3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
2
Thymoma
2
Endometrial Neoplasms
2
Uterine Prolapse
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Prostatic Diseases
1
Precancerous Conditions
1
Pelvic Organ Prolapse
1
Ovarian Neoplasms
1
Obesity, Morbid
1
Myasthenia Gravis
1
Menstruation Disturbances
1
Mediastinal Neoplasms
1
Leiomyoma
1
Hernia, Ventral
1
Hernia, Inguinal
1
Genital Diseases, Female
1
Endometriosis
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Adenomyosis
1
Interventions
fludarabine phosphate
3
Whole-Body Irradiation
3
Tacrolimus
3
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
Melphalan
3
Cyclophosphamide
3
Busulfan
3
fludarabine
2
Patient Reported Outcome Measures
2
Mesna
2
Sirolimus
1
Robotic Surgical Procedures
1
Nivolumab
1
Methotrexate
1
Hysterectomy
1
Etoposide
1
Cyclosporine
1
Bone Marrow Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Precancerous Conditions
×
Robotic Surgical Procedures
×
Clear all
NCT07120945
2026-06-02
Embrace Gyn
Medtronic - MITG
Phase NA
Active not recruiting
70 enrolled